Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders

The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders

Participants needed: 190
Trial details
Phase: Phase 2Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Bedaya HospitalUpdated: May 11, 2026Locations: 1
Eligibility criteria

GnRH antagonist IVF cycle [+1]

Hypogonadotrophic hypogonadism [+2]

Status: Not yet recruiting

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation

Participants needed: 164
Trial details
Phase: Phase 2Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Bedaya HospitalUpdated: May 6, 2026Locations: 1
Eligibility criteria

POSEIDON group 3 and 4 [+1]

Hypogonadotrophic hypogonadism [+2]

Status: Not yet recruiting

Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger

The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \[a single bolos of HCG combined with two successive doses of a GnRH agonist \] with HCG \[a single bolos administered 36 hours before oocyte retrieval \] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.

Participants needed: 196
Trial details
Phase: Phase 2Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Bedaya HospitalUpdated: May 6, 2026Locations: 1
Eligibility criteria

GnRH antagonist IVF cycle [+1]

Hypogonadotrophic hypogonadism [+2]

Status: Recruiting

Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation

The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.

Participants needed: 120
Trial details
Phase: Phase 2Age: 35-44Biological sex: FemaleType: InterventionalSponsor: Bedaya HospitalUpdated: May 4, 2026Locations: 2
Eligibility criteria

PCOS [+2]